Torax Medical tells us its highly original LINX® Gastro-esophageal reflux disease (GERD) therapy will be highlighted in several presentations at the upcoming Annual Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) meeting this week.
Torax Medical is currently marketing the LINX Reflux Management System for the treatment of GERD in the U.S. and Europe
LINX is a small implant comprised of interlinked titanium beads with magnetic cores. The magnetic attraction between the beads augments the existing esophageal sphincter’s barrier function to prevent reflux. The device is implanted using a standard minimally invasive laparoscopic procedure and is an alternative to the more anatomically disruptive fundoplication, commonly used in surgical anti-reflux procedures. The LINX Reflux Management System is indicated for those patients diagnosed with GERD as defined by abnormal pH testing, and who continue to have chronic GERD symptoms despite maximum medical therapy for the treatment of reflux.
The SAGES meeting is being held in Nashville, TN from April 14 – 18th and the LINX system features as follows, together with a number of poster presentations:
Wednesday, April 15th: Advances in Foregut Surgery: GERD in 2015: Who, What and When? Fundoplication is Out…..Place Some Magnets; Shanu Kothari, MD Gunderson Health System will present at 8:10 am in Delta Ballroom B.
Thursday, April 16th: Magnetic Sphincter Augmentation: Endoscopic and Laparoscopic Visualization of Function; Jessica L. Reynolds, MD, University of Southern California, will present the video during the Exhibit Hall Video Presentation Session from 2:00 – 4:00 PM in the Ryman Hall C – Theater.
Friday, April 17th: Multi Institutional Outcomes Using Magnetic Sphincter Augmentation Versus Nissen Fundoplication for Chronic Gastro-esophageal Reflux Disease; Jessica L. Reynolds, MD, University of Southern California, will present the findings during the Plenary 1 Session from 8:30 – 10:00 AM in Delta Ballroom A.
Charges, Complications, and Outcome: A Comparison of Laparoscopic Nissen Fundoplication Versus Magnetic Sphincter Augmentation for GERD; Jessica L. Reynolds, MD, University of Southern California, will present the findings during the Resident/Fellows Scientific Session from 3:30 – 5:30 PM in Bayou A/B.
Todd Berg, President and CEO for Torax Medical said, “It’s exciting to see surgeons independently reporting their clinical experience and success with the LINX procedure in everyday practice. The data being presented further validates the LINX is now an important treatment option for patients suffering from chronic GERD. Reflux is a sphincter disease and can have serious implications if not treated; patients need better options to address this problem.”
Source: PR Newswire